Journal: Addiction Biology
Article Title: NMDA receptor within nucleus accumbens shell regulates propofol self‐administration through D1R/ERK/CREB signalling pathway
doi: 10.1111/adb.13401
Figure Lengend Snippet: Images and plots of western blotting analysis of D1R/ERK/CREB signalling pathway in the NAc after the pretreatment of D‐AP5 in bilateral NAsh in propofol self‐administrated rats. The expressions of D1R (A, p < 0.001, n = 7, ANOVA), p‐ERK1/2 (B, p = 0.001, n = 7, Kruskal–Wallis) and p‐CREB (D, p = 0.001, n = 7, ANOVA) in the NAc were statistically significantly increased in a dose‐dependent manner by D‐AP5 pretreatment. Compared with the vehicle group, the pairwise analysis showed the difference reached a statistical significance at the dose of 2.0–4.0 μg/0.3 μL/site for D1Rs (2.0 group p < 0.001, 4.0 group p < 0.001, Dunnett) and p‐CREB (p‐CREB, 2.0 group p = 0.003, 4.0 group p = 0.001, Dunnett), and at the dose of 4.0 μg/0.3 μL/site for p‐ERK1/2 ( p = 0.001, Dunn). D‐AP5 pretreatment failed to affect the expression of t‐ERK1/2 (C, p = 0.996, n = 6, ANOVA) and t‐CREB (E, p = 0.798, n = 6, ANOVA) in the NAc. p‐ERK1/2 = phosphorylated ERK1/2, t‐ERK1/2 = total ERK1/2, p‐CREB = phosphorylated CREB, t‐NR2B = total CREB. The normally distributed data were analysed with one‐way ANOVA, and Dunnett's post hoc test was conducted for multiple comparisons; otherwise, the data that did not meet the criteria of normal distribution were analysed by Kruskal–Wallis test with Dunn's post hoc analysis for multiple comparisons. Compared with the vehicle group, ** p < 0.01, *** p < 0.001.
Article Snippet: The protein was transferred to polyvinylidene fluoride (PVDF) membranes, and the non‐specific binding sites were blocked with 5% skim milk at room temperature for 2 h. After that, the bands were incubated in primary antibody [NR2A, p‐NR2A (Tyr1246), NR2B, p‐NR2B (Tyr1472), p‐ERK and p‐CREB, rabbit, 1:1000, Cell Signaling Technology, Danvers, MA, United States; D1R, ERK and CREB, mouse, 1:1000, Santa Cruz Biotechnology, Texas, United States] at 4°C overnight and in the secondary antibody (goat anti‐rabbit or goat anti‐mouse, 1:3000, Proteintech, Chicago, United States) that diluted with tris‐buffered saline (TBST) at room temperature for 2 h. We adopted glyceraldehyde‐3‐phosphate dehydrogenase (GAPDH) (mouse, 1:10000, Proteintech, Chicago, United States) as the internal control.
Techniques: Western Blot, Expressing